{
    "2019-10-08": [
        [
            {
                "time": "2019-02-06",
                "original_text": "UPDATE 3-Jury says J&J must pay $8 bln in case over male breast growth linked to Risperdal",
                "features": {
                    "keywords": [
                        "J&J",
                        "Risperdal",
                        "jury",
                        "male breast growth",
                        "court order"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-02-06",
                "original_text": "Johnson & Johnson (JNJ) Stock Moves -0.99%: What You Should Know",
                "features": {
                    "keywords": [
                        "JNJ",
                        "stock moves",
                        "-0.99%",
                        "market reaction"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-02-06",
                "original_text": "J&J must pay $8 bln in case over male breast growth linked to Risperdal -jury",
                "features": {
                    "keywords": [
                        "J&J",
                        "Risperdal",
                        "jury",
                        "court order",
                        "male breast growth"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-02-06",
                "original_text": "[video]Johnson & Johnson Shares Fall After Hours on $8 Billion Jury Award",
                "features": {
                    "keywords": [
                        "J&J",
                        "shares fall",
                        "after hours",
                        "$8 billion jury award"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-02-06",
                "original_text": "Is Johnson & Johnson (JNJ) A Good Stock To Buy According To Hedge Funds?",
                "features": {
                    "keywords": [
                        "JNJ",
                        "hedge funds",
                        "buy recommendation"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-02-06",
                "original_text": "Teen beauty spending plunges 20% from last year to a 9-year low",
                "features": {
                    "keywords": [
                        "teen beauty spending",
                        "plunges",
                        "9-year low"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "consumer goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-02-06",
                "original_text": "Earnings Preview: Johnson & Johnson (JNJ) Q3 Earnings Expected to Decline",
                "features": {
                    "keywords": [
                        "JNJ",
                        "Q3 earnings",
                        "expected decline"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-02-06",
                "original_text": "Johnson & Johnson hit with $8bn court order over antipsychotic drug",
                "features": {
                    "keywords": [
                        "J&J",
                        "court order",
                        "antipsychotic drug",
                        "$8bn"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}